Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Motohiro Tamiya

Showing results (11-20 of 192) with videos related to

Pageof 20
Sort By:
BMC Pharmacology & Toxicology|April 5, 2020
Favorable response to pembrolizumab after durvalumab failure in a stage III sarcomatoid carcinoma of the lung: a case reportKazumi Nishino, Kei Kunimasa, Madoka Kimura, et al.
Medicine|May 17, 2018
Pembrolizumab-induced acute thrombosis: A case reportKei Kunimasa, Kazumi Nishino, Madoka Kimura, et al.
JTO Clinical and Research Reports|January 24, 2022
Cytokine Release Syndrome and Immune-Related Pneumonitis Associated With Tumor Progression in a Pulmonary Pleomorphic Carcinoma Treated With Nivolumab Plus Ipilimumab Treatment: A Case ReportKei Kunimasa, Takako Inoue, Katsunori Matsueda, et al.
Anticancer Research|October 28, 2025
Association Between Administration Timing and Efficacy of Nivolumab in Non-small Cell Lung Cancer TreatmentYuki Iwahashi, Akihiro Tamiya, Tsunehiro Tanaka, et al.
Investigational New Drugs|June 3, 2022
Dacomitinib overcomes afatinib-refractory carcinomatous meningitis in a lung cancer patient harbouring EGFR Ex.19 deletion and G724S mutation; a case reportKei Kunimasa, Naotoshi Sugimoto, Motohiro Tamiya, et al.
Lung Cancer (Amsterdam, Netherlands)|February 7, 2024
Clinical application of the Lung Cancer Compact Panel<sup>TM</sup> using various types of cytological specimens in patients with lung cancerKei Kunimasa, Motohiro Tamiya, Takako Inoue, et al.
The Journal of Liquid Biopsy|December 25, 2025
Cerebrospinal fluid ctDNA clarifies clonal divergence: leptomeningeal flare of <i>EGFR</i>-mutant disease after switch to selpercatinib for acquired <i>RET</i> fusionKei Kunimasa, Motohiro Tamiya, Takako Inoue, et al.
Thoracic Cancer|September 17, 2025
Efficacy of Atezolizumab, Bevacizumab, Carboplatin, and Paclitaxel Therapy in Patients With Genetic Alterations in Non-Small Cell Lung CancerTsunehiro Tanaka, Motohiro Tamiya, Akito Miyazaki, et al.
Thoracic Cancer|March 29, 2026
Delayed Tumor Shrinkage Beyond Progressive Disease in Small-Cell Lung Cancer Receiving Immunochemotherapy: A Case ReportTakahisa Kawamura, Kiyohide Komuta, Shun Futamura, et al.
Case Reports in Oncology|April 3, 2025
Long-Term Complete Response to Pembrolizumab in Tumor Mutation Burden-High Small Cell Lung Cancer: A Case ReportKiyohide Komuta, Kei Kunimasa, Akito Miyazaki, et al.
Pageof 20

Showing results (11-20 of 192) with videos related to

Sort By:
Pageof 20
BMC Pharmacology & Toxicology|April 5, 2020
Favorable response to pembrolizumab after durvalumab failure in a stage III sarcomatoid carcinoma of the lung: a case reportKazumi Nishino, Kei Kunimasa, Madoka Kimura, et al.
Medicine|May 17, 2018
Pembrolizumab-induced acute thrombosis: A case reportKei Kunimasa, Kazumi Nishino, Madoka Kimura, et al.
JTO Clinical and Research Reports|January 24, 2022
Cytokine Release Syndrome and Immune-Related Pneumonitis Associated With Tumor Progression in a Pulmonary Pleomorphic Carcinoma Treated With Nivolumab Plus Ipilimumab Treatment: A Case ReportKei Kunimasa, Takako Inoue, Katsunori Matsueda, et al.
Anticancer Research|October 28, 2025
Association Between Administration Timing and Efficacy of Nivolumab in Non-small Cell Lung Cancer TreatmentYuki Iwahashi, Akihiro Tamiya, Tsunehiro Tanaka, et al.
Investigational New Drugs|June 3, 2022
Dacomitinib overcomes afatinib-refractory carcinomatous meningitis in a lung cancer patient harbouring EGFR Ex.19 deletion and G724S mutation; a case reportKei Kunimasa, Naotoshi Sugimoto, Motohiro Tamiya, et al.
Lung Cancer (Amsterdam, Netherlands)|February 7, 2024
Clinical application of the Lung Cancer Compact Panel<sup>TM</sup> using various types of cytological specimens in patients with lung cancerKei Kunimasa, Motohiro Tamiya, Takako Inoue, et al.
The Journal of Liquid Biopsy|December 25, 2025
Cerebrospinal fluid ctDNA clarifies clonal divergence: leptomeningeal flare of <i>EGFR</i>-mutant disease after switch to selpercatinib for acquired <i>RET</i> fusionKei Kunimasa, Motohiro Tamiya, Takako Inoue, et al.
Thoracic Cancer|September 17, 2025
Efficacy of Atezolizumab, Bevacizumab, Carboplatin, and Paclitaxel Therapy in Patients With Genetic Alterations in Non-Small Cell Lung CancerTsunehiro Tanaka, Motohiro Tamiya, Akito Miyazaki, et al.
Thoracic Cancer|March 29, 2026
Delayed Tumor Shrinkage Beyond Progressive Disease in Small-Cell Lung Cancer Receiving Immunochemotherapy: A Case ReportTakahisa Kawamura, Kiyohide Komuta, Shun Futamura, et al.
Case Reports in Oncology|April 3, 2025
Long-Term Complete Response to Pembrolizumab in Tumor Mutation Burden-High Small Cell Lung Cancer: A Case ReportKiyohide Komuta, Kei Kunimasa, Akito Miyazaki, et al.
Pageof 20